查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
家庭化療服務市場，按產品類型、癌症類型、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419023

家庭化療服務市場，按產品類型、癌症類型、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Chemotherapy At Home Services Market, By Product Type, By Cancer Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 285 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年家庭化療服務市場規模為 15.08 億美元，2023 年至 2030 年複合CAGR為 8.5%。

家庭化療服務市場-市場動態

家庭化療服務市場的成長預計將受到不同類型癌症發生率的增加以及患者從醫院轉向家庭護理環境的成長趨勢的推動。

許多人表示願意盡可能在自己舒適的家中接受醫療照護。透過在家庭環境中提供醫療保健服務，可以提高患者的便利性並減輕頻繁去醫院就診的負擔。隨著癌症病例數量持續增加，醫療機構可能面臨越來越大的壓力和對其服務的需求。居家化療服務允許患者在非醫院環境中接受治療，有助於緩解部分壓力。根據美國國家衛生統計中心預測，2023年，美國將新增癌症病例1,958,310例，癌症相關死亡人數將達609,820例。攜帶式輸液幫浦和遠端監控設備等醫療技術的進步為家庭化療服務市場提供了成長機會。然而，重要的是要解決安全問題並考慮這些服務的有限適用性，因為它們可能會阻礙市場的成長。

居家化療服務市場 - 主要見解

  • 根據我們的研究分析師分享的分析，預計全球家庭化療服務市場在預測期內（2023-2030 年）每年將以 8.5% 左右的CAGR成長
  • 根據產品類型細分，預計 Oral 將在 2022 年顯示最大的市場佔有率
  • 根據癌症類型細分，白血病是 2022 年的主要類型
  • 按地區分類，北美是 2022 年的主要收入來源

家庭化療服務市場-細分分析：

全球家庭化療服務市場根據產品類型、癌症類型和地區進行細分。

根據產品類型，市場分為三類：口服和輸液。該市場主要由口腔領域主導。口服化療藥物有藥丸或膠囊的形式，方便患者在家服用。這為他們提供了更大的靈活性和自我管理的選擇。腫瘤科醫師通常會開立口服化療藥物，患者可以方便地從藥局取得藥物。某些藥局甚至提供口服化療藥物的專門服務。

根據癌症類型，市場分為兩類：乳癌、結腸癌、直腸癌、子宮頸癌、肺癌、攝護腺癌、卵巢癌和白血病。白血病細分市場佔據主導地位。該市場主要由白血病細分市場控制。白血病分為兩種主要形式，即急性和慢性，並進一步分為骨髓型和淋巴型。所採用的治療方法取決於白血病的確切類型和亞型。化療是白血病的常見治療方式，尤其是急性白血病。它涉及使用藥物殺死或控制白血病細胞的生長。

家庭化療服務市場 - 地理洞察

從地理來看，該市場遍佈北美、拉丁美洲、歐洲、亞太、中東和非洲等多個地區。這些區域根據參與商業活動的國家進一步分類。北美市場預計將主導成長，這主要是由於癌症治療的家庭輸液服務需求不斷成長所推動的。如果北美癌症發生率上升，對化療等癌症治療服務的需求可能會激增。這種不斷成長的需求可能會導致需要更方便、更方便患者的選擇，例如家庭服務。據估計，每年約有 170 萬美國人被診斷出罹患癌症。在診斷後一年內，四分之三的晚期癌症患者最終住院，其中六分之一的人住院三次或以上。此外，根據健康和醫學前沿報道，幾乎每個需要化療的人每天都會在醫生辦公室或門診診所度過幾個小時。由於家庭化療服務的需求不斷增加，歐洲是預測期內市場成長的第二大地區。

居家化療服務市場-競爭格局：

雖然醫院仍然是兒科癌症護理的主要地點，但在家庭環境中提供護理的趨勢日益成長。為了確保在家中為兒童提供全面和適當的護理，考慮關鍵知情人的觀點至關重要。加拿大、美國、澳洲和歐洲等國家正在擴大兒童的居家照護服務和治療，包括靜脈化療、化療後補水、低風險發燒性嗜中性白血球減少症監測和藥物輸注。製造商正在積極尋求兒童、家庭照顧者和臨床醫生的意見，以改善家庭癌症護理服務。這包括確定與在家中接受或提供護理相關的好處和挑戰，以及進行必要的修改以提高計劃的可接受性和感知有用性。製藥公司正在與家庭醫療保健提供者合作，為在家接受化療的患者提供支援服務和資源。這些合作旨在改善患者教育和遵守治療計劃。除了國家提供者之外，地方和區域家庭醫療保健機構也可以與腫瘤學家和醫院合作提供家庭化療服務，將癌症護理擴展到患者家中。

最近的發展：

2023 年 7 月，DispatchHealth 與 Reimagine Care 結成策略聯盟，以促進家庭癌症治療。此次合作減少了急診室就診次數和意外住院時間。

目錄

第 1 章：家庭化療服務市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的家庭化療服務市場片段
    • 按癌症類型分類的家庭化療服務市場片段
    • 家庭化療服務市場片段（按國家/地區）
    • 按地區分類的家庭化療服務市場片段
  • 競爭洞察

第 3 章：家庭化療服務主要市場趨勢

  • 居家化療服務市場促進因素
    • 市場促進因素的影響分析
  • 居家化療服務市場限制
    • 市場限制影響分析
  • 居家化療服務市場機會
  • 居家化療服務市場未來趨勢

第 4 章：家庭化療服務業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：居家化療服務市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：居家化療服務市場格局

  • 2022 年居家化療服務市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：家庭化療服務市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 口服
    • 點滴

第 8 章：居家化療服務市場 - 按癌症類型

  • 概述
    • 按癌症類型分類的細分市場佔有率分析
    • 乳癌
    • 結腸癌
    • 直腸癌
    • 子宮頸癌
    • 肺癌
    • 攝護腺癌
    • 卵巢癌
    • 白血病

第 9 章：居家化療服務市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 家庭化療服務北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按癌症類型）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 家庭化療服務歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按癌症類型）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 家庭化療服務亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模和預測（按癌症類型）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 家庭化療服務拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按癌症類型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 家庭化療服務中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按癌症類型）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 家庭化療服務產業

  • 競爭儀表板
  • 公司簡介
    • Sciensus Pharma Services Limited
    • Portea Medical
    • Ubiqare
    • Penn Medicine (The Trustees of the University of Pennsylvania)
    • Advocate Health Care
    • View Health Pty Ltd group (chemo@home Pty Ltd)
    • Vitalis Health and Home Care Pty Ltd
    • Medibank Private Limited
    • TCP Homecare
    • LloydsPharmacy Clinical Homecare

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2088

REPORT HIGHLIGHT

Chemotherapy At Home Services Market size was valued at USD 1,508 Million in 2022, expanding at a CAGR of 8.5% from 2023 to 2030.

Chemotherapy treatment at home offers several potential advantages. Firstly, it eliminates the need for frequent travel to hospital facilities, saving patients time and energy. Additionally, there is a reduced risk of acquiring infections that are commonly associated with hospitals. By receiving treatment in the comfort and security of their own homes, patients can experience a greater sense of ease and familiarity. This also minimizes disruptions to family life, allowing patients to maintain a sense of normalcy during their treatment. Moreover, receiving chemotherapy at home can provide patients with a heightened sense of control over their treatment and illness. To ensure accurate and up-to-date information on available services and any changes in the delivery of chemotherapy treatments, it is crucial to consult with healthcare providers or contact local healthcare authorities. While home healthcare services may be available for certain aspects of cancer care, such as home health nursing, supportive care, or palliative care, it is important to note that the administration of chemotherapy drugs may still require a controlled medical setting.

Chemotherapy At Home Services Market- Market Dynamics

The growth of the Chemotherapy At Home Services market is expected to be driven by the increasing incidence of different types of cancer and the growing trend of patients transitioning from hospital to home care settings.

Many individuals express a preference for receiving medical care in the comfort of their own homes whenever possible. By providing healthcare services in a home-based setting, it can enhance patient convenience and alleviate the burden of frequent hospital visits. As the number of cancer cases continues to rise, healthcare facilities may face increased pressure and demand for their services. Home-based chemotherapy services can help alleviate some of this pressure by allowing patients to receive treatment in a non-hospital environment. According to the National Center for Health Statistics, it is projected that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. The advancement of medical technology, such as portable infusion pumps and remote monitoring devices, presents a growth opportunity for the chemotherapy at home services market. However, it is important to address safety concerns and consider the limited applicability of these services, as they may hinder the market's growth.

Chemotherapy At Home Services Market- Key Insights

  • As per the analysis shared by our research analyst, the global Chemotherapy At Home Services market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2023-2030)
  • Based on product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Cancer Type segmentation, Leukemia was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Chemotherapy At Home Services Market- Segmentation Analysis:

The Global Chemotherapy At Home Services Market is segmented on the basis of Product Type, Cancer Type and Region.

The market is divided into three categories based on product type: Oral and Infusion. The market is primarily dominated by the oral segment. Oral chemotherapy drugs are available in the form of pills or capsules, enabling patients to conveniently take them at home. This provides them with increased flexibility and the option of self-administration. Oncologists usually prescribe oral chemotherapy, and patients can conveniently obtain their medications from pharmacies. Certain pharmacies even provide specialized services for dispensing oral chemotherapy.

The market is divided into two categories based on Cancer Type: Breast Cancer, Colon Cancer, Rectum Cancer, Cervix Uteri Cancer, Lung Cancer, Prostate Cancer, Ovarian Cancer and Leukemia. Leukemia segment dominates the market. The market is predominantly controlled by the leukemia segment. Leukemia is classified into two main forms, namely acute and chronic, and further divided into myeloid and lymphoid types. The treatment methods employed depend on the precise type and subtype of leukemia. Chemotherapy is a common treatment modality for leukemia, particularly for acute forms. It involves the use of drugs to kill or control the growth of leukemia cells.

Chemotherapy At Home Services Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market in North America is expected to dominate the growth, primarily driven by the increasing demand for home infusion services for cancer treatment. In the event of a rise in cancer incidence in North America, there would likely be a surge in the demand for cancer treatment services, such as chemotherapy. This growing demand could lead to a need for more convenient and patient-friendly options like home-based services. It is estimated that approximately 1.7 million Americans are diagnosed with cancer each year. Within a year of diagnosis, three-quarters of those with advanced cancer end up being hospitalized, with 1 in 6 individuals being hospitalized three or more times. Additionally, almost everyone requiring chemotherapy spends several hours a day in physician offices or outpatient clinics, as reported by the frontiers of health and medicine. Europe holds the second-largest region for market growth during the forecast period, owing to the increasing demand for home-based chemotherapy services.

Chemotherapy At Home Services Market- Competitive Landscape:

While hospitals continue to be the primary location for pediatric cancer care, there is a growing trend towards providing care in the home setting. To ensure that comprehensive and appropriate care is delivered to children in their homes, it is crucial to consider the perspectives of key informants. Countries such as Canada, the United States, Australia, and Europe are expanding their home care services and treatments for children, including intravenous chemotherapy, post-chemotherapy hydration, monitoring of low-risk febrile neutropenia, and medication infusions. Manufacturers are actively seeking input from children, family caregivers, and clinicians to improve home-based cancer care services. This includes identifying the benefits and challenges associated with receiving or providing care at home, as well as making necessary modifications to enhance program acceptability and perceived usefulness. Pharmaceutical companies are collaborating with home healthcare providers to offer support services and resources for patients undergoing chemotherapy at home. These collaborations aim to improve patient education and adherence to treatment plans. In addition to national providers, local and regional home healthcare agencies may also offer at-home chemotherapy services in partnership with oncologists and hospitals, thereby extending cancer care to patients' homes.

Recent Developments:

In July 2023, a strategic alliance was formed between DispatchHealth and Reimagine Care to facilitate at-home cancer treatment. The collaboration lowers emergency room visits and unanticipated hospital stays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET KEY PLAYERS

  • Portea Medical
  • Ubiqare
  • Penn Medicine (The Trustees of the University of Pennsylvania)
  • Advocate Health Care
  • View Health Pty Ltd group (chemo@home Pty Ltd)
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited
  • TCP Homecare
  • LloydsPharmacy Clinical Homecare

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY PRODUCT TYPE

  • Oral
  • Infusion

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY CANCER TYPE

  • Breast Cancer
  • Colon Cancer
  • Rectum Cancer
  • Cervix Uteri Cancer
  • Lung Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Leukemia

GLOBAL CHEMOTHERAPY AT HOME SERVICES MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chemotherapy At Home Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chemotherapy At Home Services Market Snippet by Product Type
    • 2.1.2. Chemotherapy At Home Services Market Snippet by Cancer Type
    • 2.1.3. Chemotherapy At Home Services Market Snippet by Country
    • 2.1.4. Chemotherapy At Home Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Chemotherapy At Home Services Key Market Trends

  • 3.1. Chemotherapy At Home Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chemotherapy At Home Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chemotherapy At Home Services Market Opportunities
  • 3.4. Chemotherapy At Home Services Market Future Trends

4. Chemotherapy At Home Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chemotherapy At Home Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chemotherapy At Home Services Market Landscape

  • 6.1. Chemotherapy At Home Services Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chemotherapy At Home Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
    • 7.1.3. Infusion

8. Chemotherapy At Home Services Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2022 & 2030 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Colon Cancer
    • 8.1.4. Rectum Cancer
    • 8.1.5. Cervix Uteri Cancer
    • 8.1.6. Lung Cancer
    • 8.1.7. Prostate Cancer
    • 8.1.8. Ovarian Cancer
    • 8.1.9. Leukemia

9. Chemotherapy At Home Services Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Chemotherapy At Home Services Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Chemotherapy At Home Services Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Chemotherapy At Home Services Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Chemotherapy At Home Services Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Chemotherapy At Home Services Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Chemotherapy At Home Services Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Sciensus Pharma Services Limited
    • 10.2.2. Portea Medical
    • 10.2.3. Ubiqare
    • 10.2.4. Penn Medicine (The Trustees of the University of Pennsylvania)
    • 10.2.5. Advocate Health Care
    • 10.2.6. View Health Pty Ltd group (chemo@home Pty Ltd)
    • 10.2.7. Vitalis Health and Home Care Pty Ltd
    • 10.2.8. Medibank Private Limited
    • 10.2.9. TCP Homecare
    • 10.2.10. LloydsPharmacy Clinical Homecare

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Chemotherapy At Home Services Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Chemotherapy At Home Services Market, by Product Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Cancer Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Chemotherapy At Home Services Market, by Cancer Type 2018-2030 (USD Million)
  • TABLE Chemotherapy At Home Services Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Chemotherapy At Home Services Market, by Region 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Chemotherapy At Home Services Market, by Cancer Type, 2018-2030 (USD Million)